These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11131282

  • 1. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
    Watanabe S, Ono H, Ishimitsu T, Matsuoka H, Ono Y, Fujimori T.
    Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
    [Abstract] [Full Text] [Related]

  • 2. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661
    [Abstract] [Full Text] [Related]

  • 3. Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
    Inada H, Ono H, Minami J, Ishimitsu T, Matsuoka H.
    Hypertens Res; 2002 May; 25(3):433-40. PubMed ID: 12135323
    [Abstract] [Full Text] [Related]

  • 4. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
    Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H.
    J Hypertens; 2004 Jul; 22(7):1389-95. PubMed ID: 15201556
    [Abstract] [Full Text] [Related]

  • 5. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [Abstract] [Full Text] [Related]

  • 6. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Feb; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats.
    Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED.
    Hypertension; 2001 Dec 01; 38(6):1300-6. PubMed ID: 11751707
    [Abstract] [Full Text] [Related]

  • 8. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y, Ono H, Frohlich ED.
    J Hypertens; 1996 Jul 01; 14(7):823-8. PubMed ID: 8818920
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y, Ono H, Frohlich ED.
    Hypertension; 1999 Aug 01; 34(2):273-8. PubMed ID: 10454453
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May 01; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 11. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S, Nishikimi T, Inaba C, Akimoto K, Matsuoka H.
    J Hypertens; 2008 Sep 01; 26(9):1837-48. PubMed ID: 18698220
    [Abstract] [Full Text] [Related]

  • 12. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K, Kanno Y, Hayashi K, Takenaka T, Saruta T.
    Clin Exp Hypertens; 1998 Apr 01; 20(3):295-312. PubMed ID: 9605384
    [Abstract] [Full Text] [Related]

  • 13. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M, Ogawa T, Han WH, Takabatake T.
    Clin Exp Pharmacol Physiol; 1999 Sep 01; 26(9):674-9. PubMed ID: 10499155
    [Abstract] [Full Text] [Related]

  • 14. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
    Shudo C, Masuda Y, Sugita H, Furukawa S, Hayashi K, Hirata H, Tanaka S, Tomita K.
    Gen Pharmacol; 1994 Dec 01; 25(8):1567-75. PubMed ID: 7721030
    [Abstract] [Full Text] [Related]

  • 15. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M, Notoya M, Kohda Y, Yamashita J, Takashita Y, Gemba M.
    Hypertens Res; 2002 Sep 01; 25(5):751-5. PubMed ID: 12452329
    [Abstract] [Full Text] [Related]

  • 16. Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Qiu C, Bruneval P, Roeckel A, Heudes D, Duong Van Huyen JP, Roux S.
    J Hypertens; 1999 Oct 01; 17(10):1489-95. PubMed ID: 10526911
    [Abstract] [Full Text] [Related]

  • 17. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 01; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 18. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
    Cheng MC, Wu TH, Huang LT, Tain YL.
    Pediatr Neonatol; 2014 Jun 01; 55(3):189-95. PubMed ID: 24268813
    [Abstract] [Full Text] [Related]

  • 19. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL.
    Hypertension; 1996 Jan 01; 27(1):49-55. PubMed ID: 8591887
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
    Francischetti A, Ono H, Frohlich ED.
    Hypertension; 1998 Mar 01; 31(3):795-801. PubMed ID: 9495263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.